Satellogic Insider Sale: Kargieman Disposes 88,280 SATL Shares
Rhea-AI Filing Summary
Insider sale disclosed by Emiliano Kargieman, CEO and director of Satellogic Inc. (SATL). The Form 4 shows two open-market dispositions: 73,089 Class A shares sold on 08/26/2025 at $3.75 per share and 15,191 Class A shares sold on 08/27/2025 at $3.75 per share. After these transactions he beneficially owned 2,911,720 Class A shares. The filing was signed by an attorney-in-fact on 08/28/2025. No derivative transactions were reported.
Positive
- Timely and complete disclosure of insider sales on Form 4
- No derivative or option transactions reported, simplifying analysis
Negative
- Insider sold 88,280 shares (73,089 + 15,191) in two transactions, which may be viewed negatively by some investors
Insights
TL;DR: A routine insider sale by the CEO/director with clear reporting; no derivatives reported.
The reported transactions are ordinary open-market sales of Class A common stock executed on consecutive days at the same price of $3.75 per share. The filings indicate continued significant ownership post-sale (2,911,720 shares), suggesting the sales reduced but did not eliminate the reporting person’s stake. The report is timely and includes the required signature by an attorney-in-fact. From a disclosure standpoint this is straightforward and does not disclose any new material corporate events.
TL;DR: Governance controls appear followed; sales were reported on Form 4 without listed 10b5-1 plan.
The Form 4 identifies Emiliano Kargieman as CEO, director and 10% owner and shows open-market dispositions on 08/26/2025 and 08/27/2025. The filing does not indicate these transactions were made pursuant to a 10b5-1 trading plan. The presence of an attorney-in-fact signature is acceptable procedure for filings. No indications of option exercises, grants, or other derivative activity are present in Table II.
FAQ
What transactions did Emiliano Kargieman report on Form 4 for SATL?
How many SATL shares does Kargieman own after the reported sales?
Were any derivative securities reported by the insider?
Did the filing state the sales were pursuant to a 10b5-1 trading plan?
Who signed the Form 4 for Emiliano Kargieman?